Baltimore, MD — June 15, 2026 – As former NBA player Tristan Thompson’s recent disclosure about undergoing a vasectomy continues to drive public discussion, Dr. Arthur L. Burnett II, world-renowned urologist at Johns Hopkins University School of Medicine and a leading expert in men’s sexual and reproductive health, is highlighting what the moment reveals about changing attitudes toward men’s reproductive health and the misconceptions that still persist.

Blavity Health, the health and wellness vertical of Blavity, a leading Black-owned digital media company, is focused on delivering culturally relevant, expert-reviewed health information. Serving Black millennials and Gen Z, Blavity Health provides accessible, medically vetted content on health education, prevention, and wellness. With a media network that reaches over 100 million readers monthly across its digital platforms and social channels, Blavity Health is a trusted and influential source for health information within Black communities.

Dr. Burnett highlighted that the growing visibility of vasectomy in celebrity conversations reflects a broader cultural shift in how men approach family planning, masculinity, and sexual health.

“High-profile discussions around vasectomy can help normalize conversations around men’s reproductive health and shared responsibility in family planning,” said Dr. Burnett. “One of the most common misconceptions I encounter is that vasectomy affects masculinity, sexual performance or hormone levels. In reality, the procedure does not reduce testosterone production or sexual function.”

Vasectomy remains one of the most commonly performed and effective forms of permanent contraception in the United States, with more than 500,000 procedures performed annually. It is a minimally invasive outpatient procedure that does not affect libido, erectile function, or testosterone levels.

However, Dr. Burnett cautions that increased visibility and simplified public narratives can still lead to misunderstanding particularly around permanence and reversibility.

“For the right candidate, it can be a safe, effective and highly reliable option for permanent contraception,” he noted. “But it is still a permanent decision, and patients should fully understand that context before proceeding.”

The discussion also underscores that vasectomy provides no protection against sexually transmitted infections and requires follow-up testing to confirm sterility after the procedure.

Dr. Burnett encourages men and couples to approach vasectomy as part of long-term reproductive planning, grounded in accurate medical understanding rather than cultural trends or misconceptions.

Read the full article here.

For interview requests with Dr. Arthur Burnett, please contact Tomika Anderson at tomika@manifestgreatnessmedia.com

World-renowned Men’s Health Expert Featured in The Root Discusses the Growing Debate Over Low Testosterone, Masculinity, and Evidence-Based Care

Baltimore, MD — June 2, 2026 – As conversations surrounding masculinity, aging, and men’s health continue to dominate social media and public discourse, internationally recognized urologist and men’s health expert Dr. Arthur L. Burnett is helping separate medical fact from cultural hype in a new feature published by The Root titled, “Is Low Testosterone the Real Problem? Expert Weighs In.”

The Root is a leading digital media platform covering Black news, culture, politics, health, and social commentary. It is widely recognized for shaping national conversations on issues affecting Black communities and broader American society. The platform reaches millions of readers annually across its digital channels, with a diverse and highly engaged audience that includes professionals, academics, and general readers seeking cultural insight and analysis.

In the article, Dr. Burnett offers expert insight into the increasing attention being given to testosterone levels among men and addresses widespread misconceptions surrounding so-called “Low T.” His commentary arrives at a critical moment as growing numbers of men seek testosterone-related treatments amid rising concerns about energy, sexual health, physical performance, and overall well-being.

“Many symptoms commonly attributed to low testosterone may actually reflect broader health concerns that deserve comprehensive medical evaluation,” said Dr. Burnett. “The goal should not simply be to chase a hormone level, but to understand the underlying factors affecting a patient’s health and quality of life.”

A distinguished professor of urology at Johns Hopkins Medicine and a leading authority on male sexual and reproductive health, Dr. Burnett has spent decades advancing research and clinical care related to erectile dysfunction, testosterone deficiency, men’s sexual health, and aging.

The Root feature explores the growing cultural fascination with testosterone and examines whether declining energy, reduced libido, mood changes, and other symptoms are always directly linked to hormone levels. Dr. Burnett emphasizes the importance of individualized medical assessment, evidence-based treatment, and avoiding one-size-fits-all solutions.

His perspective reinforces a key message often overlooked in public discussions: testosterone is only one component of a much larger health picture that includes cardiovascular health, sleep quality, metabolic conditions, mental health, lifestyle habits, and aging-related changes.

As Men’s Health Month highlights the importance of preventive care and early intervention, Dr. Burnett encourages men to engage in informed conversations with qualified healthcare providers rather than relying solely on social media trends or marketing-driven narratives.

Read the full article here.

For interview requests with Dr. Arthur Burnett, please contact Tomika Anderson at the details below.

Baltimore, MD — April 23, 2026 – As prostate health remains a critical yet often overlooked men’s health issue, internationally recognized urologist Dr. Arthur Burnett of Johns Hopkins University is featured across two leading podcasts, Ask The Good Doctor, hosted by Dr. LaJoyce Brookshire, and Unzipping Taboos, hosted by Dr. Sue and Charlie, to advance a unified public health message centered on honest, stigma-free dialogue about prostate cancer, early detection, and the cultural and systemic barriers that continue to delay care. Both episodes offered a clear, medically grounded insight into prostate health, diagnosis, and treatment. 

Ask The Good Doctor, hosted by Dr. LaJoyce Brookshire, is a widely distributed wellness platform focused on preventive health, holistic education, and culturally relevant medical guidance. The show reaches a broad digital audience across YouTube, where it has generated nearly 200,000 total views, positioning it as a growing voice in accessible health education.

Unzipping Taboos, hosted by Dr. Sue and Charlie, is a candid health and sexuality-focused podcast hosted under Milstein Health Consulting. Known for its stigma-free, open dialogue format, the show engages audiences through honest discussions that break down fear and misinformation around sexual and reproductive health. The show has released 70+ episodes and maintains an active listener base within niche wellness, education, and sexuality-focused communities.

Prostate cancer affects approximately one in nine men and one in six Black men. Because it often develops without symptoms, many cases are diagnosed late. Dr. Burnett emphasizes:

“Symptoms don’t necessarily mean cancer and no symptoms does not mean everything is fine,” said Dr. Burnett.

In Ask The Good Doctor, Dr. Burnett explains PSA testing and its limitations. Elevated results do not automatically indicate cancer but require follow-up evaluation.He also addresses common misconceptions about prostate enlargement and masculinity, noting that risk cannot be determined by body size or strength. Early detection, he stresses, remains one of the strongest tools for improving outcomes.

The conversations explore advances in nerve-sparing surgery and precision medicine, which have improved outcomes and recovery. However, Dr. Burnett notes that all treatments, surgery or radiation, may affect sexual function, and outcomes depend on overall health, timing of diagnosis, and individual risk factors. He also explains that medications like Viagra or Cialis may help some men but are not universally effective.

A key theme across both podcasts is how cultural expectations around masculinity discourage men from seeking care. Dr. Burnett urges earlier action:

“Waiting for symptoms is not a safe strategy. Early testing and open conversation can save lives.”

He also highlights the importance of partners and families in encouraging men to get screened.

Not all prostate cancers require immediate treatment. Many low-risk cases can be managed through active surveillance with regular monitoring. Dr. Burnett stresses that surveillance is an active, structured medical process, not a delay in care. He encourages patients to ask critical questions about risk level, treatment options, and long-term quality-of-life outcomes.

Audiences are encouraged to listen to both Ask The Good Doctor and Unzipping Taboos for a deeper understanding of prostate health, early detection, and the importance of breaking silence around men’s health.

Baltimore, MD — April 16, 2026 – World-renowned urologist and men’s health expert Dr. Arthur Burnett is featured in ESSENCE, offering critical medical insight on testicular cancer awareness and early detection, in conjunction with lifestyle influencer Obio Jones sharing his personal diagnosis journey.

ESSENCE is a leading media, technology, and commerce company dedicated to Black women and communities, reaching a global audience of more than 20 million across its print, digital, social, and live platforms.

The feature comes during Testicular Cancer Awareness Month and underscores the importance of early detection, routine care, and open conversations around men’s health—particularly among younger men and underserved communities.

Jones, 33, revealed his diagnosis earlier this year after experiencing symptoms for months before seeking medical attention. Following early detection, he underwent a successful radical orchiectomy, highlighting the importance of timely intervention.

Dr. Burnett, a professor of urology at Johns Hopkins School of Medicine, reinforces that testicular cancer is highly treatable when caught early and emphasizes the need for men to become more familiar with their bodies and proactive in seeking care.

“Most men who develop testicular cancer notice a change themselves first,” said Dr. Burnett. “Awareness and early action can dramatically improve outcomes.”

In the ESSENCE feature, Dr. Burnett outlines key guidance for men:

• Be familiar with what is normal for your body
• Do not ignore symptoms such as lumps, swelling, or discomfort
• Maintain a relationship with a healthcare provider
• Address stigma and normalize conversations around men’s reproductive health

The article also highlights broader cultural barriers, particularly within Black communities, where stigma and medical mistrust can delay care and worsen outcomes.

“This is not about fear—it’s about awareness, ownership, and action,” Dr. Burnett added.

This national feature positions Dr. Burnett as a leading voice in advancing conversations around men’s health, sexual health, and early detection practices.

You may read the full article here.

Media Opportunity: Men’s Health Month (June)

As conversations around men’s health continue to gain urgency, particularly leading into Men’s Health Month this June, Dr. Arthur Burnett is available for additional media opportunities, including broadcast segments, expert commentary, contributed columns, and feature stories.

With deep expertise spanning sexual health, prostate cancer, and early detection advocacy, Dr. Burnett can speak to emerging trends in how men are engaging with their health, the cultural factors influencing delayed care, and the critical importance of proactive, preventive approaches.

For interview requests, segment bookings, or editorial contributions, please contact the media representative listed below.

Baltimore, MD — April 6, 2026 – Dr. Arthur Burnett is spotlighting encouraging early findings on a novel investigational immunotherapy in a recent Healthgrades feature, a leading online health platform that reaches more than 7.7 million users each month. The coverage offers hope for patients with advanced, treatment-resistant prostate cancer.

Healthgrades is a leading online healthcare resource that helps patients find and connect with doctors, hospitals, and trusted medical information. Healthgrades is also part of the larger RVO Health network, which collectively engages 100 million+ unique health and wellness seekers every month across its portfolio of trusted brands.

VIR-5500 (also called AMX-500) is an experimental immunotherapy being tested in early clinical trials for men whose prostate cancer no longer responds to standard treatments. It works by helping the immune system identify and attack cancer cells more precisely. Early results were shared at the American Society of Clinical Oncology Genitourinary Cancers Symposium in February 2026, though the data have not yet been published in a peer-reviewed journal.

VIR-5500 is engineered to remain inactive in the bloodstream and activate only within the tumor, helping T cells target cancer cells while minimizing damage to healthy tissue.

“These findings are an encouraging early signal,” said Dr. Burnett. “The experimental immunotherapy VIR-5500 is particularly notable for its mechanism, it redirects the patient’s own T cells to recognize and attack cancer cells that would otherwise evade detection.”

Early-phase results suggest the therapy is generally well tolerated, with mostly mild side effects. It also showed early signs of effectiveness, including lowering PSA levels, an important marker of prostate cancer, in patients receiving higher doses. Dr. Burnett emphasized that while these findings are promising, larger studies are needed to fully evaluate the therapy’s safety and long-term effectiveness.

This expert perspective was featured on Healthgrades, a leading online healthcare resource that provides patients and caregivers with trusted information on emerging treatments and connects them with top doctors and hospitals.

You may read the full article here.